Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.4K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.4K
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

51
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
51
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

49
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
49
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

429
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
429
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

444
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
444
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

299
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
299

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systems biology-based drug repurposing for neuroinflammation treatment in activated human microglia.

Scientific reports·2026
Same author

From gene correlations to cell clusters: COTAN improved scRNA-seq analysis.

NAR genomics and bioinformatics·2026
Same author

A descriptor-free machine learning framework to improve antigen discovery for bacterial pathogens.

PloS one·2025
Same author

Acute cholecystitis and subtotal cholecystectomy.

World journal of emergency surgery : WJES·2025
Same author

Home-Based Intervention Tool for Cardiac Telerehabilitation: Protocol for a Controlled Trial.

JMIR research protocols·2025
Same author

International nursing students and clinical learning environments: A convergent mixed-methods study.

Nurse education in practice·2024

Related Experiment Video

Updated: Mar 3, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.7K

Graphical Modeling Meets Systems Pharmacology.

Rosario Lombardo1, Corrado Priami1,2,3

  • 1The Microsoft Research, University of Trento Centre for Computational and Systems Biology (COSBI), Trento, Italy.

Gene Regulation and Systems Biology
|May 5, 2017
PubMed
Summary
This summary is machine-generated.

Poor communication hinders systems projects. The bStyle tool uses a cartoon-like graphical language for clear communication, enabling system modeling, analysis, and simulations for better drug mechanism understanding in systems pharmacology.

Keywords:
Graphical modelingdata analysisdesign tools and techniquesmodeling and simulationstochastic and hybrid simulation algorithmsuser-centered design

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.7K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Related Experiment Videos

Last Updated: Mar 3, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.7K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.7K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Area of Science:

  • Systems pharmacology
  • Computational biology
  • Bioinformatics

Background:

  • Systems projects, including systems pharmacology, often fail due to poor stakeholder communication and misaligned expectations.
  • A unified, unambiguous language is crucial for successful project collaboration and execution.

Purpose of the Study:

  • To introduce bStyle, a novel modeling tool designed to bridge communication gaps in systems projects.
  • To facilitate a common understanding and data exchange among diverse project stakeholders.

Main Methods:

  • Development of bStyle, a tool employing a graphical language.
  • The language is designed to be intuitive (cartoon-like) yet formal enough for robust modeling.
  • Integration of data analysis and dynamic simulation capabilities within the bStyle application.

Main Results:

  • bStyle provides a common media for exchanging ideas and data, enhancing collaboration.
  • The tool enables formal modeling, analysis, and dynamic simulations of complex systems.
  • Integrated data analysis and simulation support the understanding of drug mechanisms.

Conclusions:

  • bStyle enhances communication and expectation alignment in systems pharmacology projects.
  • The tool's graphical language and integrated simulation capabilities are vital for understanding drug actions.
  • bStyle supports the core aspects of systems pharmacology through improved modeling and analysis.